Reaction
Ocular Vasculitis reporting signals
As of the last recalculation, Ocular Vasculitis appears in 169 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 694.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 36 | 694.9 | 698.0 |
| Aflibercept | 23 | 104.9 | 105.0 |
| Ranibizumab | 8 | 38.9 | 38.9 |